Hangzhou Ao Rui Biological Technology Co .
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $14M
Investors
- 6
About Hangzhou Ao Rui Biological Technology Co .
,Ltd operates as a biotechnology company that focuses on technology development for non-invasive early screening and diagnosis of digestive system tumors. The core research team has over 30 employees and the company has many certifications, such as high-tech enterprise by Zhejiang province, and Hangzhou Double Hundred Plan. The company cooperates with more than 200 hospitals, such as Peking Union Medical College Hospital, Beijing People's Hospital and Tongji Hospital. In January 2021, it passed the high-tech enterprises and provincial high-tech enterprise R&D center certification. The company is based on circulating tumor DNA (ctDNA) methylation assay and provides various single-cancer and multi-cancer screening products for patients with liver, stomach, intestines, esophagus and pancreas. Products include Liweian and Xiaoweian. Besides, it uses non-invasive blood-free DNA methylation testing technology and two-layer machine learning analytics algorithms for big data AI analytics to develop Oriomics-HRLB+ Oriomics-DLML. The company will invest in clinical registration and marketing of early liver cancer screening products and early GI multi-cancer screening products, and R&D of single-cancer and pan-cancer early screening and diagnostic products.
Who invested in Hangzhou Ao Rui Biological Technology Co .
6 investors across 2 rounds
See all investors in Hangzhou Ao Rui Biological Technology Co .
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hangzhou Ao Rui Biological Technology Co .
Who invested in Hangzhou Ao Rui Biological Technology Co .?
Hangzhou Ao Rui Biological Technology Co . has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Ao Rui Biological Technology Co . raised?
Hangzhou Ao Rui Biological Technology Co . has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hangzhou Ao Rui Biological Technology Co . last raise money?
Hangzhou Ao Rui Biological Technology Co .'s most recent round on record is a Series B, in Sep 2023.
What does Hangzhou Ao Rui Biological Technology Co . do?
,Ltd operates as a biotechnology company that focuses on technology development for non-invasive early screening and diagnosis of digestive system tumors.
Where is Hangzhou Ao Rui Biological Technology Co . headquartered?
Hangzhou Ao Rui Biological Technology Co . is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Ao Rui Biological Technology Co .?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Hangzhou Ao Rui Biological Technology Co .'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Hangzhou Ao Rui Biological Technology Co .? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.